Cost-Effectiveness Modelling of a 3-Month Tight Control Patient Management of Rheumatoid Arthritis with Certolizumab Pegol in France

Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1487
https://www.valueinhealthjournal.com/article/S1098-3015(13)03392-5/fulltext
Title : Cost-Effectiveness Modelling of a 3-Month Tight Control Patient Management of Rheumatoid Arthritis with Certolizumab Pegol in France
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03392-5&doi=10.1016/j.jval.2013.08.1487
First page : A562
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1333
Categories :
Tags :
Regions :
ViH Article Tags :